IP Library Granted Patent US 7,393,360
Granted Patent B2
US 7,393,360 · App. 11/045,773 · Granted Jul 1, 2008

Implantable prosthetic valve

Assignee: Edwards Lifesciences PVT, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,393,360
App. No.
11/045,773
Granted
Jul 1, 2008
Kind
B2
Abstract

A valve prosthesis device is disclosed suitable for implantation in body ducts. The device comprises support stent, comprised of a deployable construction adapted to be initially crimped in a narrow configuration suitable for catheterization through the body duct to a target location and adapted to be deployed by exerting substantially radial forces from within by means of a deployment device to a deployed state in the target location, the support stent provided with a plurality of longitudinally rigid support beams of fixed length; valve assembly comprising a flexible conduit having an inlet end and an outlet, made of pliant material attached to the support beams providing collapsible slack portions of the conduit at the outlet. When flow is allowed to pass through the valve prosthesis device from the inlet to the outlet the valve assembly is kept in an open position, whereas a reverse flow is prevented as the collapsible slack portions of the valve assembly collapse inwardly providing blockage to the reverse flow.

Claims (24)

1. A method for deploying a valve device at the natural aortic valve position at the entrance to the left ventricle of a myocardium of a patient, comprising:

radially collapsing a deployable implantable valve device having a collapsible and expandable support stent and a collapsible and expandable valve assembly, the support stent comprising a first portion configured to expand to a first diameter and a second portion configured to expand to a second diameter, the first diameter being smaller than the second diameter and wherein the valve assembly is sutured to the support stent;

advancing the collapsed valve device through the patient's vasculature towards the natural aortic valve position via a catheterization technique;

positioning the valve device such that the valve assembly is located substantially within an annulus of a natural aortic valve; and

radially expanding the first and second portions such that the first portion engages leaflets of the natural aortic valve and the second portion engages an inner wall of an ascending aorta above the opening of the coronary arteries;

wherein, after implantation, the valve assembly allows blood to flow in a first direction and prevents blood from flowing in a second direction and wherein the first and second portions of the support stent are configured to resist migration of the valve assembly;

wherein, after implantation, the support stent has a third diameter positioned at the level of the coronary arteries, the third diameter being substantially less than an inner diameter of the ascending aorta such that a radial gap is provided between the support stent and the opening of the coronary arteries.

2. The method of claim 1 , further comprising advancing a guidewire through the patient's vasculature to facilitate advancement of the valve device via a catheterization technique.

3. The method of claim 2 , wherein the valve device is advanced over the guidewire and around the aortic arch.

4. The method of claim 1 , wherein a balloon catheter is used to assist in the radial expansion of the first and second portions of the support stent.

5. The method of claim 4 , wherein the balloon catheter has a first inflatable portion for expanding the first portion of the support stent and a second inflatable portion for expanding the second portion of the support stent.

6. The method of claim 1 , wherein the valve assembly is formed of natural tissue.

7. The method of claim 1 , wherein the valve assembly is formed of pericardial tissue.

8. The method of claim 1 , wherein the support stent is formed of a shape memory alloy.

9. The method of claim 1 , wherein the valve assembly is adhered to the first portion of the support stent.

10. A method for deploying a valve device at the natural aortic valve position at the entrance to the left ventricle of a myocardium of a patient, comprising:

radially collapsing an implantable valve device having a collapsible and expandable support stent formed of a shape memory material and a collapsible and expandable valve assembly formed of pericardial tissue, the support stent comprising a lower portion configured to expand to a first diameter and an upper portion configured to expand to a second diameter, the first diameter being smaller than the second diameter and wherein the valve assembly is sutured to the support stent at an inlet end and is sutured to the support stent along three commissural points for support three valve leaflets;

advancing a guidewire through the patient's vasculature and around the aortic arch;

advancing the collapsed valve device over the guidewire towards the natural aortic valve position via a catheterization technique;

positioning the valve device such that the valve assembly is located within an annulus of a natural aortic valve; and

radially expanding the support stent such that the lower portion engages leaflets of the natural aortic valve and the upper portion engages an inner wall of an ascending aorta;

wherein, after implantation, the valve assembly allows blood to flow in a first direction and prevents blood from flowing in a second direction and wherein the lower and upper portions of the support stent are configured to resist migration of the valve assembly;

wherein the support stent further comprises a central portion between the lower and upper portion, the central portion being shaped to provide a radial gap between the support stent and the inner wall of the ascending aorta at the openings of the coronary arteries.

11. The method of claim 10 , further comprising inflating a balloon within the valve device to assist in the radial expansion of the lower and upper portions of the support stent.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2016
From: SPENSER, BENJAMIN; BENICHOU, NETANEL; BASH, ASSAF; ZAKAI, AVRAHAM
To: PERCUTANEOUS VALVE TECHNOLOGIES, INC
Reel/Frame 037892/0360 →
CHANGE OF NAME Recorded Mar 4, 2016
From: PERCUTANEOUS VALVE TECHNOLOGIES, INC
To: EDWARDS LIFESCIENCES PVT, INC
Reel/Frame 038007/0521 →
CHANGE OF NAME Recorded Apr 29, 2005
From: PERCUTANEOUS VALVE TECHNOLOGIES, INC.
To: EDWARDS LIFESCIENCES PVT, INC.
Reel/Frame 016185/0718 →
Continuity (2)
Division 0997575000 · Oct 11, 2001
Related Publication 20050192665A1 · Sep 1, 2005